Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Wolff

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry Letters|August 8, 2008
2-Substituted piperazine-derived imidazole carboxamides as potent and selective CCK1R agonists for the treatment of obesityRichard Berger, Cheng Zhu, Alexa R Hansen, et al.
EES Solar|August 7, 2025
Point contacts in halide perovskite solar cells: from reduced interfacial recombination to increased ionic field screeningGuorui He, Andrés-Felipe Castro-Méndez, Jonas Diekmann, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 2010
Anthranilic acid replacements in a niacin receptor agonistDarby Schmidt, Abigail Smenton, Subharekha Raghavan, et al.
Journal of Medicinal Chemistry|December 23, 2016
Discovery of N-[Bis(4-methoxyphenyl)methyl]-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an Orally Active Pan-Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase 1-3 (HIF PHD1-3) for the Treatment of AnemiaJohn S Debenham, Christina Madsen-Duggan, Matthew J Clements, et al.
Journal of Lipid Research|October 30, 2012
Nicotinic acid and DP1 blockade: studies in mouse models of atherosclerosisAlison M Strack, Ester Carballo-Jane, Sheng-Ping Wang, et al.
Bioorganic & Medicinal Chemistry Letters|April 7, 2019
Accelerating the discovery of DGAT1 inhibitors through the application of parallel medicinal chemistry (PMC)Yang Yu, Zhicai Wu, Zhi-Cai Shi, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Potent DGAT1 Inhibitors in the Benzimidazole Class with a Pyridyl-oxy-cyclohexanecarboxylic Acid MoietyShuwen He, Qingmei Hong, Zhong Lai, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2019
Benzimidazole-based DGAT1 inhibitors with a [3.1.0] bicyclohexane carboxylic acid moietyShuwen He, Zhong Lai, Qingmei Hong, et al.
Journal of Medicinal Chemistry|February 28, 2012
1,3,8-Triazaspiro[4.5]decane-2,4-diones as efficacious pan-inhibitors of hypoxia-inducible factor prolyl hydroxylase 1-3 (HIF PHD1-3) for the treatment of anemiaPetr Vachal, Shouwu Miao, Joan M Pierce, et al.
ACS Medicinal Chemistry Letters|October 29, 2014
Discovery of a Potent and Selective DGAT1 Inhibitor with a Piperidinyl-oxy-cyclohexanecarboxylic Acid MoietyShuwen He, Qingmei Hong, Zhong Lai, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|August 8, 2008
2-Substituted piperazine-derived imidazole carboxamides as potent and selective CCK1R agonists for the treatment of obesityRichard Berger, Cheng Zhu, Alexa R Hansen, et al.
EES Solar|August 7, 2025
Point contacts in halide perovskite solar cells: from reduced interfacial recombination to increased ionic field screeningGuorui He, Andrés-Felipe Castro-Méndez, Jonas Diekmann, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 2010
Anthranilic acid replacements in a niacin receptor agonistDarby Schmidt, Abigail Smenton, Subharekha Raghavan, et al.
Journal of Medicinal Chemistry|December 23, 2016
Discovery of N-[Bis(4-methoxyphenyl)methyl]-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an Orally Active Pan-Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase 1-3 (HIF PHD1-3) for the Treatment of AnemiaJohn S Debenham, Christina Madsen-Duggan, Matthew J Clements, et al.
Journal of Lipid Research|October 30, 2012
Nicotinic acid and DP1 blockade: studies in mouse models of atherosclerosisAlison M Strack, Ester Carballo-Jane, Sheng-Ping Wang, et al.
Bioorganic & Medicinal Chemistry Letters|April 7, 2019
Accelerating the discovery of DGAT1 inhibitors through the application of parallel medicinal chemistry (PMC)Yang Yu, Zhicai Wu, Zhi-Cai Shi, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Potent DGAT1 Inhibitors in the Benzimidazole Class with a Pyridyl-oxy-cyclohexanecarboxylic Acid MoietyShuwen He, Qingmei Hong, Zhong Lai, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2019
Benzimidazole-based DGAT1 inhibitors with a [3.1.0] bicyclohexane carboxylic acid moietyShuwen He, Zhong Lai, Qingmei Hong, et al.
Journal of Medicinal Chemistry|February 28, 2012
1,3,8-Triazaspiro[4.5]decane-2,4-diones as efficacious pan-inhibitors of hypoxia-inducible factor prolyl hydroxylase 1-3 (HIF PHD1-3) for the treatment of anemiaPetr Vachal, Shouwu Miao, Joan M Pierce, et al.
ACS Medicinal Chemistry Letters|October 29, 2014
Discovery of a Potent and Selective DGAT1 Inhibitor with a Piperidinyl-oxy-cyclohexanecarboxylic Acid MoietyShuwen He, Qingmei Hong, Zhong Lai, et al.
Pageof 7